SCHEMBL793791

SCHEMBL793791

CC(C)(Oc1ccc(Cl)cc1)C(=O)N1CCN(c2nc(N)nc3sc(-c4ccccc4)cc23)CC1.Nc1nc(N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)c2nc(-c3ccc(F)cc3)[nH]c2n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PI4KB Q9UBF8 4/20 0.47
LMNA P02545 4/20 0.38
ALDH1A1 P00352 3/20 0.38
TSHR P16473 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
KDM4E B2RXH2 2/20 0.38
HSD17B10 Q99714 1/20 0.38
ADORA2B P29275 2/20 0.37
ADORA2A P29274 1/20 0.37
ADORA1 P30542 1/20 0.37
CNR2 P34972 1/20 0.37
P2RY12 Q9H244 1/20 0.37
ENPP2 Q13822 2/20 0.36
KCNH2 Q12809 1/20 0.36
MAPT P10636 3/20 0.35
HTT P42858 3/20 0.35
MAPK1 P28482 2/20 0.35
KIT P10721 1/20 0.35
NPSR1 Q6W5P4 2/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1693971 0.95 PI4KB (0.45) PI4KBLMNAALDH1A1TSHRSMN1; SMN2
SCHEMBL654125 0.83 CNR2 (0.52) PI4KBLMNAALDH1A1TSHRSMN1; SMN2
SCHEMBL653839 0.83 PI4KB (0.61) PI4KBLMNAALDH1A1TSHRSMN1; SMN2
SCHEMBL655731 0.82 PI4KB (0.59) PI4KBLMNAALDH1A1TSHRSMN1; SMN2
SCHEMBL656328 0.81 PI4KB (0.63) PI4KBLMNAALDH1A1TSHRSMN1; SMN2
SCHEMBL654795 0.81 ENPP2 (0.52) PI4KBLMNAALDH1A1TSHRSMN1; SMN2
SCHEMBL655005 0.80 PI4KB (0.57) PI4KBLMNASMN1; SMN2ADORA2BADORA2A
SCHEMBL654042 0.79 PI4KB (0.56) PI4KBLMNAALDH1A1TSHRSMN1; SMN2
SCHEMBL654187 0.79 PI4KB (0.48) PI4KBLMNAALDH1A1TSHRSMN1; SMN2
SCHEMBL1720411 0.79 PI4KB (0.57) PI4KBLMNAALDH1A1TSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2616077-A1 ANTI-CANCER ACTIVITY OF NOVEL BICYCLIC HETEROCYCLES Katholieke Universiteit Leuven, K.U. Leuven R&D (BE) 2013-07-24 EP disclosed
EP-2575969-A1 ANTIVIRAL ACTIVITY OF NOVEL BICYCLIC HETEROCYCLES Katholieke Universiteit Leuven, K.U. Leuven R&D (BE) 2013-04-10 EP disclosed
WO-2012035423-A1 ANTI-CANCER ACTIVITY OF NOVEL BICYCLIC HETEROCYCLES KATHOLIEKE UNIVERSITEIT LEUVEN, K.U. LEUVEN R&D (BE) 2012-03-22 WO disclosed
EP-2405973-A2 THIAZOLOPYRIMIDINE MODULATORS AS IMMUNOSUPPRESSIVE AGENTS Katholieke Universiteit Leuven, K.U. Leuven R&D (BE) 2012-01-18 EP disclosed
WO-2010103130-A2 NOVEL BICYCLIC HETEROCYCLES KATHOLIEKE UNIVERSITEIT LEUVEN, K.U.LEUVEN R&D (BE) 2010-09-16 WO disclosed